BDH Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 7:42 pm

Quick Insight

BDH Industries Ltd, a pharmaceutical company, currently trades at a price of 283 with a market cap of 163 Cr. At a P/E ratio of 17.1, the stock seems reasonably valued, supported by a healthy ROE of 14.2% and ROCE of 17.8%. The company's OPM stands at 17.23%, indicating efficient operational performance. With promoters holding 49.67% and a low FII stake of 0.28%, the stock appears to have strong insider support. The company's strong ICR of 184.18x reflects its robust ability to meet interest obligations. Overall, BDH Industries presents a stable investment opportunity in the pharmaceutical sector, given its solid financial metrics and shareholder structure.

Competitors of BDH Industries Ltd

All Competitor Stocks of BDH Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:30 pm

Below is a detailed analysis of the quarterly data for BDH Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 18.62 Cr.. The value appears strong and on an upward trend. It has increased from 17.82 Cr. (Mar 2025) to 18.62 Cr., marking an increase of 0.80 Cr..
• For Expenses, as of Jun 2025, the value is 16.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.75 Cr. (Mar 2025) to 16.50 Cr., marking an increase of 1.75 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.12 Cr.. The value appears to be declining and may need further review. It has decreased from 3.07 Cr. (Mar 2025) to 2.12 Cr., marking a decrease of 0.95 Cr..
• For OPM %, as of Jun 2025, the value is 11.39%. The value appears to be declining and may need further review. It has decreased from 17.23% (Mar 2025) to 11.39%, marking a decrease of 5.84%.
• For Other Income, as of Jun 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 0.57 Cr. (Mar 2025) to 0.55 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.44 Cr.. The value appears to be declining and may need further review. It has decreased from 3.40 Cr. (Mar 2025) to 2.44 Cr., marking a decrease of 0.96 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.76% (Mar 2025) to 25.00%, marking a decrease of 1.76%.
• For Net Profit, as of Jun 2025, the value is 1.83 Cr.. The value appears to be declining and may need further review. It has decreased from 2.49 Cr. (Mar 2025) to 1.83 Cr., marking a decrease of 0.66 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.18. The value appears to be declining and may need further review. It has decreased from 4.32 (Mar 2025) to 3.18, marking a decrease of 1.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:44 pm

Below is a detailed analysis of the balance sheet data for BDH Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.76 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.76 Cr..
• For Reserves, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.40 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 6.60 Cr..
• For Borrowings, as of Mar 2025, the value is 0.98 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 8.69 Cr. (Mar 2024) to 0.98 Cr., marking a decrease of 7.71 Cr..
• For Other Liabilities, as of Mar 2025, the value is 17.20 Cr.. The value appears to be improving (decreasing). It has decreased from 22.57 Cr. (Mar 2024) to 17.20 Cr., marking a decrease of 5.37 Cr..
• For Total Liabilities, as of Mar 2025, the value is 86.94 Cr.. The value appears to be improving (decreasing). It has decreased from 93.42 Cr. (Mar 2024) to 86.94 Cr., marking a decrease of 6.48 Cr..
• For Fixed Assets, as of Mar 2025, the value is 19.66 Cr.. The value appears to be declining and may need further review. It has decreased from 20.35 Cr. (Mar 2024) to 19.66 Cr., marking a decrease of 0.69 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.35 Cr..
• For Other Assets, as of Mar 2025, the value is 66.93 Cr.. The value appears to be declining and may need further review. It has decreased from 72.72 Cr. (Mar 2024) to 66.93 Cr., marking a decrease of 5.79 Cr..
• For Total Assets, as of Mar 2025, the value is 86.94 Cr.. The value appears to be declining and may need further review. It has decreased from 93.42 Cr. (Mar 2024) to 86.94 Cr., marking a decrease of 6.48 Cr..

Notably, the Reserves (63.00 Cr.) exceed the Borrowings (0.98 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for BDH Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.68, marking a decrease of 0.46.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.43. It has increased from 105.67 (Mar 24) to 119.43, marking an increase of 13.76.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.43. It has increased from 107.96 (Mar 24) to 119.43, marking an increase of 11.47.
• For Dividend / Share (Rs.), as of Mar 25, the value is 4.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 4.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 115.52. It has decreased from 149.08 (Mar 24) to 115.52, marking a decrease of 33.56.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 23.35. This value is within the healthy range. It has decreased from 24.33 (Mar 24) to 23.35, marking a decrease of 0.98.
• For PBIT / Share (Rs.), as of Mar 25, the value is 21.78. This value is within the healthy range. It has decreased from 23.33 (Mar 24) to 21.78, marking a decrease of 1.55.
• For PBT / Share (Rs.), as of Mar 25, the value is 21.65. This value is within the healthy range. It has decreased from 23.02 (Mar 24) to 21.65, marking a decrease of 1.37.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
• For PBDIT Margin (%), as of Mar 25, the value is 20.21. This value is within the healthy range. It has increased from 16.32 (Mar 24) to 20.21, marking an increase of 3.89.
• For PBIT Margin (%), as of Mar 25, the value is 18.85. This value is within the healthy range. It has increased from 15.65 (Mar 24) to 18.85, marking an increase of 3.20.
• For PBT Margin (%), as of Mar 25, the value is 18.74. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.74, marking an increase of 3.31.
• For Net Profit Margin (%), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 10. It has increased from 11.49 (Mar 24) to 13.94, marking an increase of 2.45.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.48. This value is below the healthy minimum of 15. It has decreased from 16.22 (Mar 24) to 13.48, marking a decrease of 2.74.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.90. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 17.90, marking a decrease of 3.50.
• For Return On Assets (%), as of Mar 25, the value is 10.66. This value is within the healthy range. It has increased from 10.56 (Mar 24) to 10.66, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.01, marking a decrease of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.98 (Mar 24) to 0.73, marking a decrease of 0.25.
• For Current Ratio (X), as of Mar 25, the value is 3.95. This value exceeds the healthy maximum of 3. It has increased from 2.37 (Mar 24) to 3.95, marking an increase of 1.58.
• For Quick Ratio (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 2. It has increased from 2.20 (Mar 24) to 3.51, marking an increase of 1.31.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 9.81 (Mar 24) to 6.84, marking a decrease of 2.97.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 23.33 (Mar 24) to 0.00, marking a decrease of 23.33.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.05 (Mar 24) to 0.00, marking a decrease of 22.05.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 76.67 (Mar 24) to 0.00, marking a decrease of 76.67.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.95 (Mar 24) to 0.00, marking a decrease of 77.95.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 184.18. This value is within the healthy range. It has increased from 77.26 (Mar 24) to 184.18, marking an increase of 106.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 128.03. This value is within the healthy range. It has increased from 55.43 (Mar 24) to 128.03, marking an increase of 72.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 121.21. It has decreased from 145.85 (Mar 24) to 121.21, marking a decrease of 24.64.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has increased from 1.70 (Mar 24) to 1.82, marking an increase of 0.12.
• For EV / EBITDA (X), as of Mar 25, the value is 9.02. This value is within the healthy range. It has decreased from 10.41 (Mar 24) to 9.02, marking a decrease of 1.39.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.28, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 76.66 (Mar 24) to 0.00, marking a decrease of 76.66.
• For Price / BV (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 2.67 (Mar 24) to 2.20, marking a decrease of 0.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.28, marking an increase of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness